Azar plans to reshape Medicare drug coverage

HHS Secretary Alex Azar brought the Trump administration’s drug pricing plan into sharper focus Monday, making it clear that he is considering administrative steps that could reshape the Medicare drug marketplace. Changes under consideration include shifting some or all Part B drugs to Part D, eliminating disincentives for Part D plans to negotiate lower prices of drugs in protected classes, and scaling back

Read the full 632 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE